COMPLETE SE STENT SYSTEM
Report
- Report Number
- 2953200-2010-00137
- Event Type
- Injury
- Date Received
- February 3, 2010
- Date of Event
- November 12, 2009
- Report Date
- January 8, 2010
- Manufacturer
- MEDTRONIC CARDIOVASCULAR
- Product Code
- FGE
- PMA / PMN Number
- K062264
- Removal / Correction Number
- NA
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- GM
- Reporter Occupation
- PHYSICIAN
- Health Professional
- Yes
Narratives
(B) (4) EVALUATION RESULTS: (REVASCULARIZATION).
THE PT HAD 2 COMPLETE SE STENTS IMPLANTED, 1 STENT IMPLANTED TO THE POPLITEAL ARTERY (PPA) AND 1 IMPLANTED TO THE MID/DISTAL SUPERFICIAL FEMORAL ARTERY (SFA) (MFR REPORT # 2953200-2009-01786). BOTH LESIONS ARE REPORTED TO BE SEVERELY CALCIFIED. THE STENTS WERE DEPLOYED SUCCESSFULLY. ONE MONTH POST INDEX PROCEDURE, THE PT REQUIRED HOSPITALIZATION OF CARDIAC ISCHEMIA. VASCULAR INTERVENTION WAS PERFORMED. THE INVESTIGATOR INDICATED THAT THE REPORTED EVENT WAS NOT RELATED TO THE STUDY DEVICE. APPROX 6.5 MONTHS POST INDEX PROCEDURE, THE PT SUFFERED SEVERE CLAUDICATION IN THE RIGHT CALF/BUTTOCK. THE PT WAS HOSPITALIZED AND TARGET VESSEL REVASCULARIZATION WAS PERFORMED. THE PT IS CONTINUING WITH TREATMENT. THE INVESTIGATOR INDICATED THAT THE REPORTED EVENT WAS RELATED TO THE STUDY STENT. COMPLETE SE IS NOT APPROVED FOR USE IN THE U.S. FOR SFA INDICATION, BUT IS SIMILAR TO COMPLETE SE WHICH IS APPROVED FOR BILIARY INDICATION.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | COMPLETE SE STENT SYSTEM | FGE | MEDTRONIC CARDIOVASCULAR | NA | V00164466 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 72 YR | Male | Required Intervention | ASPIRIN 24 HRS PRIOR TO EVENT. | THE PT WAS TAKING CLOPIDOGREL &.| THE PT WAS TAKING CLOPIDOGREL &| ASPIRIN 24 HRS PRIOR TO EVENT. |